H.C. Wainwright Reiterates Buy Rating on Lexicon Pharmaceuticals (LXRX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.49 | 52 Week High | $19.62 | |||
| Open | $1.49 | 52 Week Low | $7.65 | |||
| Day High | $1.49 | P/E | N/A | |||
| Day Low | $1.49 | EPS | $-0.22 | |||
| Volume | 150 | |||||
